Virginia Biotechnology Association
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 411,282 | 391,312 | 19,970 | 14.1 | 59% |
| 2012 | 538,554 | 476,488 | 62,066 | 13.2 | 50% |
| 2013 | 528,359 | 602,074 | −73,715 | 9.0 | 54% |
| 2014 | 482,828 | 412,773 | 70,055 | 15.1 | 56% |
| 2015 | 609,164 | 575,322 | 33,842 | 11.5 | 41% |
| 2016 | 559,117 | 616,944 | −57,827 | 9.6 | 45% |
| 2017 | 651,877 | 614,979 | 36,898 | 10.4 | 44% |
| 2018 | 668,347 | 667,348 | 999 | 9.6 | 48% |
| 2019 | 877,989 | 813,802 | 64,187 | 8.8 | 41% |
| 2020 | 709,257 | 725,352 | −16,095 | 9.6 | 48% |
| 2021 | 690,493 | 634,603 | 55,890 | 12.1 | 55% |
| 2022 | 728,390 | 948,407 | −220,017 | 5.3 | 43% |
| 2023 | 1,198,368 | 1,186,187 | 12,181 | 4.3 | 40% |
In its most recent public year (2023), this organization brought in $12,181 more than it spent. Its reserves stood at about 4.3 months of spending, down from 14.1 in 2011. Staff pay was 40% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works